Zhao Yunge, Lyons Charles E, Xiao Aizhen, Templeton Dennis J, Sang Qingxiang Amy, Brew Keith, Hussaini Isa M
Department of Pathology, University of Virginia, 415 Lane Road, MR5 Rm3332, Charlottesville, VA 22908, USA.
Biochem Biophys Res Commun. 2008 May 16;369(4):1215-20. doi: 10.1016/j.bbrc.2008.03.038. Epub 2008 Mar 18.
Previous reports showed that urokinase plasminogen activator (uPA) converts plasminogen to plasmin which then activates matrix metalloproteinases (MMPs). Here, we report that uPA directly cleaved pro-MMP-9 in a time-dependent manner at both C- and N-terminus and generated two gelatinolytic bands. uPA-activated-MMP-9 efficiently degraded fibronectin and blocked by uPA inhibitor B428 and recombinant tissue inhibitor of metalloproteinase-1 (TIMP-1). B428 inhibited basal and PMA-induced active MMP-9 in glioblastomas (GBM) U1242 cell media as well as cell invasion in vitro. A combination of MMP-9 and uPA antibodies more significantly inhibited U1242 cell invasion than uPA or MMP-9 antibody alone. Both uPA and MMP-9 were highly expressed in U1242 cell and GBM patient specimens. Furthermore, two active MMP-9 fragments with identical molecular weights to the uPA-activated MMP-9 products were detected in GBM patient specimens. These results suggest that uPA-mediated direct activation of MMP-9 may promote GBM cell invasion.
先前的报道表明,尿激酶型纤溶酶原激活剂(uPA)可将纤溶酶原转化为纤溶酶,进而激活基质金属蛋白酶(MMPs)。在此,我们报道uPA能以时间依赖的方式在C端和N端直接切割前MMP-9,并产生两条明胶酶解带。uPA激活的MMP-9能有效降解纤连蛋白,并被uPA抑制剂B428和重组金属蛋白酶组织抑制剂-1(TIMP-1)所阻断。B428可抑制胶质母细胞瘤(GBM)U1242细胞培养基中基础状态及佛波酯(PMA)诱导的活性MMP-9,以及体外细胞侵袭。MMP-9和uPA抗体联合使用比单独使用uPA或MMP-9抗体更显著地抑制U1242细胞侵袭。uPA和MMP-9在U1242细胞和GBM患者标本中均高表达。此外,在GBM患者标本中检测到两个与uPA激活的MMP-9产物分子量相同的活性MMP-9片段。这些结果表明,uPA介导的MMP-9直接激活可能促进GBM细胞侵袭。